Charity Partners

Little Way Cancer Support

QR Code for Little Way Cancer Support

Cancer and Neurodivergence

Little Way Cancer Support Centre

The Little Way Cancer Support Centre was set up in October 2003 to provide support for cancer patients, their families and friends. The diagnosis of cancer can mark the beginning of a long and frightening journey, not just for the person who has received the diagnosis, but also for their family and friends.
While medical concerns are addressed through the range of treatments available within the Health Services, many people feel their emotional needs and those of their family and friends and not met. The Little Way Cancer Support Centre aims to meet this need by providing emotional support and practical help to people who have or have had cancer , their families and friends.
Where your money goes
All money raised goes directly towards providing services for our cancer patients and their families in our county.
We have professional counsellors and a holistic therapist at the house who provide one to one conselling and complementary therapies.
All our services are free of charge!
Research on the prevalence of cancer among neurodivergent individuals is still evolving, and there isn’t a vast amount of data specifically addressing this intersection. However, there are some studies and discussions that shed light on the topic.

One study published in the journal “Autism Research” in 2018 suggested a potential link between autism spectrum disorder (ASD) and cancer risk. The study, titled “Cancer Incidence in Persons With Autism Spectrum Disorder: A Meta‐Analysis,” conducted a meta-analysis of existing literature and found a higher incidence of cancer among individuals with ASD compared to the general population. However, the study also highlighted the need for further research to better understand this association and its underlying mechanisms.

 

Similarly, a review article titled “Cancer risk in individuals with autism spectrum disorders” published in the journal “Journal of Autism and Developmental Disorders” in 2017 discussed several studies that have investigated the potential relationship between ASD and cancer risk. While some studies reported an increased risk of certain types of cancer among individuals with ASD, the authors emphasized the limitations of the existing research and called for more comprehensive studies to explore this topic further.
It’s important to note that the research in this area is still relatively limited, and more studies are needed to fully understand the prevalence of cancer among neurodivergent individuals, including those with autism spectrum disorder and other neurodevelopmental conditions.

References

Hansen, S. N., Schendel, D. E., & Parner, E. T. (2018). Explaining the Increase in the Prevalence of Autism Spectrum Disorders: The Proportion Attributable to Changes in Reporting Practices. JAMA Pediatrics, 172(2), 187–193. https://doi.org/10.1001/jamapediatrics.2017.3895
Sandin, S., Schendel, D., Magnusson, P., Hultman, C., Surén, P., Susser, E., Grønborg, T., Gissler, M., & Gunnes, N. (2016). Autism risk associated with parental age and with increasing difference in age between the parents. Molecular Psychiatry, 21(5), 693–700. https://doi.org/10.1038/mp.2015.70
Lyall, K., Croen, L., Daniels, J., Fallin, M. D., Ladd-Acosta, C., Lee, B. K., Park, B. Y., Snyder, N. W., Schendel, D., Volk, H., Windham, G. C., & Newschaffer, C. (2017). The changing epidemiology of autism spectrum disorders. Annual Review of Public Health, 38, 81–102. https://doi.org/10.1146/annurev-publhealth-031816-044318